Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 629, pseudogene (RN7SL629P)

Target
RN7SL629P
Molecular classification
Pseudogene, Non-coding RNA-derived locus
01

Overview

RN7SL629P is a pseudogene, meaning it is a genomic copy of a functional gene (in this case, the 7SL RNA gene, essential for the signal recognition particle) that has lost its ability to encode a functional product[1][2][5]. Pseudogenes like RN7SL629P are formed by reverse transcription of RNA into DNA, followed by integration into the genome; they often exhibit truncations or sequence differences compared to the original gene[2][5]. RN7SL629P does not produce any protein or RNA known to have biological or pathological activity. Its parent molecule, 7SL RNA, is essential for protein translocation in the signal recognition particle but the pseudogene has no known direct functions or disease associations[3][4]. Summary of key points: - RN7SL629P is a non-functional pseudogene, not a druggable or disease-linked target. - It is important to flag the entry as "is_incorrect: true" in drug or target databases, as pseudogenes like RN7SL629P should not be identified as functional molecular targets for therapy or biomarker development[1][2][5].

Other names
RN7SL629P
02

Mechanism of action

Not applicable

03

Biological functions

None established for RN7SL629P itself; parent 7SL RNA functions in signal recognition particle assembly
04

Disease associations

None known for RN7SL629P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 629, pseudogene (RN7SL629P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 629, pseudogene (RN7SL629P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call